BioMed Central journals see growth in impact

July 03, 2015

A total of 175 journals in BioMed Central's publishing portfolio now have impact iactors in the recently published Journal Citation Report 2015, of which 104 journals rank in the top half of their categories.

Nine journals received their first impact factor. Biology of Sex Differences gained an impact factor of 4.84, placing it in the top quartile of both of its categories of Endocrinology & Metabolism and Genetics & Heredity. Infectious Diseases of Poverty received an impact factor of 4.11, placing it in the top quartile of the Infectious Diseases category.

Xiao-Nong Zhou, Editor-in-Chief of Infectious Diseases of Poverty from the National Institute of Parasitic Diseases, China, said: "We are thrilled with the impressive success of Infectious Diseases of Poverty. Open access publishing through BioMed Central has allowed us to gain a wider global audience since the journal launched in 2012. I am particularly proud that we have provided free access to researchers from developing countries who are not able to pay for normal journal subscriptions. With collective efforts from our editorial team and BioMed Central, we believe the journal will lead to more actions that address the recommendations from the WHO's Global Report for Research on Infectious Diseases of Poverty."

Molecular Neurodegeneration is now the highest ranking open access journal in the Neurosciences category, with an impact factor of 6.56, and overall is one of the highest ranked journals dedicated to neurodegeneration research.

Guojun Bu, co-Editor-in-Chief of Molecular Neurodegeneration, said: "We are extremely pleased that the impact factor for Molecular Neurodegeneration has been increasing over the past several years. This trend reflects the impact and quality of the articles we publish. It also coincides with the growing interest in addressing the mechanisms and therapy of various neurodegenerative diseases by investigators and the public alike."

BioMed Central's flagship journals have also seen increases in their impact factors over the last year. Genome Biology now has an impact factor of 10.81. This makes it seventh out of all 167 journals in the Genetics & Heredity category and the highest ranking open access journal in both of its categories. It is also the highest ranking open access journal in the Biotechnology and Applied Microbiology category according to its Eigenfactor - a measure which takes into account how often the journal is cited in a highly-cited journal.

BMC Biology's impact factor has grown to 7.98, making it fourth out of 85 journals in the Biology category. BMC Medicine is the second highest ranking open access journal in the Medicine, General & Internal category, with an impact factor of 7.25, and ranks 10 out of 153 journals in that category overall. The journal has also had articles with an Altmetric score of over 900 - a measure that takes into account an article's impact in terms of news coverage and social media.

Since transferring to BioMed Central in 2008, the Journal of Experimental & Clinical Cancer Research has seen its impact factor rise each year to a current high of 4.43. This places it in the top quartile of the Oncology category.

Genetics Selection Evolution is the highest ranking journal in the Agriculture, Dairy & Animal Science category, with an impact factor of 3.82. The society journal, owned by the French government agency for agriculture, has seen continuous growth in its impact factor since it transferred to BioMed Central in 2009.

Deborah Kahn, Executive Vice-President at BioMed Central, said: "The results from this year's Journal Citation Report demonstrate the strength and breadth of BioMed Central's portfolio. We've seen impressive increases across several measures for our journals in priority research areas such as neuroscience, oncology and biotechnology. We're also pleased to see that it's not only our more established journals that are continuing to rise the ranks, but that several of our newer journals are clearly having an increasing impact in their fields. This is a reflection of the dedication and diligence of the editors and societies working on those journals, and of all our authors."
Media Contact
Joel Winston
Media Officer
BioMed Central
T: +44 (0)20 3192 2081
M: +44 (0)7766540147

Notes for editors

1. BioMed Central is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.

BioMed Central

Related Infectious Diseases Articles from Brightsurf:

Understanding the spread of infectious diseases
Physicists at M√ľnster University (Germany) have shown in model simulations that the COVID-19 infection rates decrease significantly through social distancing.

Forecasting elections with a model of infectious diseases
Election forecasting is an innately challenging endeavor, with results that can be difficult to interpret and may leave many questions unanswered after close races unfold.

COVID-19 a reminder of the challenge of emerging infectious diseases
The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC).

Certain antidepressants could provide treatment for multiple infectious diseases
Some antidepressants could potentially be used to treat a wide range of diseases caused by bacteria living within cells, according to work by researchers in the Virginia Commonwealth University School of Medicine and collaborators at other institutions.

Opioid epidemic is increasing rates of some infectious diseases
The US faces a public health crisis as the opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections.

Infectious diseases could be diagnosed with smartphones in sub-Saharan Africa
A new Imperial-led review has outlined how health workers could use existing phones to predict and curb the spread of infectious diseases.

The Lancet Infectious Diseases: Experts warn of a surge in vector-borne diseases as humanitarian crisis in Venezuela worsens
The ongoing humanitarian crisis in Venezuela is accelerating the re-emergence of vector-borne diseases such as malaria, Chagas disease, dengue, and Zika virus, and threatens to jeopardize public health gains in the country over the past two decades, warn leading public health experts.

Glow-in-the-dark paper as a rapid test for infectious diseases
Researchers from Eindhoven University of Technology (The Netherlands) and Keio University (Japan) present a practicable and reliable way to test for infectious diseases.

Math shows how human behavior spreads infectious diseases
Mathematics can help public health workers better understand and influence human behaviors that lead to the spread of infectious disease, according to a study from the University of Waterloo.

Many Americans say infectious and emerging diseases in other countries will threaten the US
An overwhelming majority of Americans (95%) think infectious and emerging diseases facing other countries will pose a 'major' or 'minor' threat to the U.S. in the next few years, but more than half (61%) say they are confident the federal government can prevent a major infectious disease outbreak in the US, according to a new national public opinion survey commissioned by Research!America and the American Society for Microbiology.

Read More: Infectious Diseases News and Infectious Diseases Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to